So, who is getting all those free drug samples, anyway? The poor, or the wealthy insured? A recent study puts this to the test. Some refreshing candor - Novartis CEO Dan Vasella admits that he uses …
Pharma News 12_17
Some interesting oncology results: Millennium's Velcade used in combo therapy for multiple myeloma shows impressive results. Cephalon's Treanda shows impressive remission numbers for CLL, and …